Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Action potential (AP) (1)
- Agrin (1)
- Amphetamine (1)
- Bacteria (1)
- Brain (1)
-
- Central nervous system (1)
- Cocaine (1)
- Dendritic excitability (1)
- Department of Neurosciences (1)
- Depression-related behaviors (1)
- Drosophila (1)
- Drug addiction (1)
- Eph receptors (1)
- Epitranscriptomic alterations (1)
- Etiology (1)
- Fibronectin type III domain (1)
- Infection (1)
- Kinase activation (1)
- Kir2 (1)
- LRP4 (1)
- LTP (1)
- Lambert-Eaton myasthenic syndrome (LEMS) (1)
- Ligand-binding domain (1)
- M1 muscarinic receptor (1)
- Neurological disease (1)
- Neuromuscular junction (1)
- Neuromuscular junction (NMJ) (1)
- Neuronal Nsun2-deficiency (1)
- Neurotransmitter release (1)
- Parkinson’s disease (1)
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication Or Cognitive-Behavior Therapy In Treatment-Naive Depression., Hua-Hsin Tai, Jungho Cha, Faezeh Vedaei, Boadie W Dunlop, W Edward Craighead, Helen S Mayberg, Ki Sueng Choi
Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication Or Cognitive-Behavior Therapy In Treatment-Naive Depression., Hua-Hsin Tai, Jungho Cha, Faezeh Vedaei, Boadie W Dunlop, W Edward Craighead, Helen S Mayberg, Ki Sueng Choi
Department of Neuroscience Faculty Papers
Background: Hippocampal atrophy has been consistently reported in major depressive disorder with more recent focus on subfields. However, literature on hippocampal volume changes after antidepressant treatment has been limited. The first-line treatments for depression include antidepressant medication (ADM) or cognitive-behavior therapy (CBT). To understand the differential effects of CBT and ADM on the hippocampus, we investigated the volume alterations of hippocampal subfields with treatment, outcome, and chronicity in treatment-naïve depression patients. Methods: Treatment-naïve depressed patients from the PReDICT study were included in this analysis. A total of 172 patients who completed 12 weeks of randomized treatment with CBT (n …
The Ephb2 Receptor Uses Homotypic, Head-To-Tail Interactions Within Its Ectodomain As An Autoinhibitory Control Mechanism, Yan Xu, Dorothea Robev, Nayanendu Saha, Bingcheng Wang, Matthew B. Dalva, Kai Xu, Juha P. Himanen, Dimitar B. Nikolov
The Ephb2 Receptor Uses Homotypic, Head-To-Tail Interactions Within Its Ectodomain As An Autoinhibitory Control Mechanism, Yan Xu, Dorothea Robev, Nayanendu Saha, Bingcheng Wang, Matthew B. Dalva, Kai Xu, Juha P. Himanen, Dimitar B. Nikolov
Department of Neuroscience Faculty Papers
The Eph receptor tyrosine kinases and their ephrin ligands direct axon pathfinding and neuronal cell migration, as well as mediate many other cell–cell communication events. Their dysfunctional signaling has been shown to lead to various diseases, including cancer. The Ephs and ephrins both localize to the plasma membrane and, upon cell–cell contact, form extensive signaling assemblies at the contact sites. The Ephs and the ephrins are divided into A and B subclasses based on their sequence conservation and affinities for each other. The molecular details of Eph–ephrin recognition have been previously revealed and it has been documented that ephrin binding …
Neuronal Nsun2 Deficiency Produces Trna Epitranscriptomic Alterations And Proteomic Shifts Impacting Synaptic Signaling And Behavior., J Blaze, A Navickas, H L Phillips, S Heissel, A Plaza-Jennings, S Miglani, H Asgharian, M Foo, C D Katanski, C P Watkins, Z T Pennington, B Javidfar, S Espeso-Gil, B Rostandy, H Alwaseem, C G Hahn, H Molina, D J Cai, T Pan, W D Yao, H Goodarzi, F Haghighi, S Akbarian
Neuronal Nsun2 Deficiency Produces Trna Epitranscriptomic Alterations And Proteomic Shifts Impacting Synaptic Signaling And Behavior., J Blaze, A Navickas, H L Phillips, S Heissel, A Plaza-Jennings, S Miglani, H Asgharian, M Foo, C D Katanski, C P Watkins, Z T Pennington, B Javidfar, S Espeso-Gil, B Rostandy, H Alwaseem, C G Hahn, H Molina, D J Cai, T Pan, W D Yao, H Goodarzi, F Haghighi, S Akbarian
Department of Neuroscience Faculty Papers
Epitranscriptomic mechanisms linking tRNA function and the brain proteome to cognition and complex behaviors are not well described. Here, we report bi-directional changes in depression-related behaviors after genetic disruption of neuronal tRNA cytosine methylation, including conditional ablation and transgene-derived overexpression of Nsun2 in the mouse prefrontal cortex (PFC). Neuronal Nsun2-deficiency was associated with a decrease in tRNA m5C levels, resulting in deficits in expression of 70% of tRNAGly isodecoders. Altogether, 1488/5820 proteins changed upon neuronal Nsun2-deficiency, in conjunction with glycine codon-specific defects in translational efficiencies. Loss of Gly-rich proteins critical for glutamatergic neurotransmission was associated with impaired …
Caldag-Gefi Mediates Striatal Cholinergic Modulation Of Dendritic Excitability, Synaptic Plasticity And Psychomotor Behaviors., Jill R. Crittenden, Shenyu Zhai, Magdalena Sauvage, Takashi Kitsukawa, Eric Burguière, Morgane Thomsen, Hui Zhang, Cinzia Costa, Giuseppina Martella, Veronica Ghiglieri, Barbara Picconi, Karen A. Pescatore, Ellen M. Unterwald, Walker S. Jackson, David E. Housman, S. Barak Caine, David Sulzer, Paolo Calabresi, Anne C. Smith, D. James Surmeier, Ann M. Graybiel
Caldag-Gefi Mediates Striatal Cholinergic Modulation Of Dendritic Excitability, Synaptic Plasticity And Psychomotor Behaviors., Jill R. Crittenden, Shenyu Zhai, Magdalena Sauvage, Takashi Kitsukawa, Eric Burguière, Morgane Thomsen, Hui Zhang, Cinzia Costa, Giuseppina Martella, Veronica Ghiglieri, Barbara Picconi, Karen A. Pescatore, Ellen M. Unterwald, Walker S. Jackson, David E. Housman, S. Barak Caine, David Sulzer, Paolo Calabresi, Anne C. Smith, D. James Surmeier, Ann M. Graybiel
Department of Neuroscience Faculty Papers
CalDAG-GEFI (CDGI) is a protein highly enriched in the striatum, particularly in the principal spiny projection neurons (SPNs). CDGI is strongly down-regulated in two hyperkinetic conditions related to striatal dysfunction: Huntington's disease and levodopa-induced dyskinesia in Parkinson's disease. We demonstrate that genetic deletion of CDGI in mice disrupts dendritic, but not somatic, M1 muscarinic receptors (M1Rs) signaling in indirect pathway SPNs. Loss of CDGI reduced temporal integration of excitatory postsynaptic potentials at dendritic glutamatergic synapses and impaired the induction of activity-dependent long-term potentiation. CDGI deletion selectively increased psychostimulant-induced repetitive behaviors, disrupted sequence learning, and eliminated M1R blockade of cocaine self-administration. …
Conservation And Innovation: Versatile Roles For Lrp4 In Nervous System Development., Alison T. Depew, Timothy J. Mosca
Conservation And Innovation: Versatile Roles For Lrp4 In Nervous System Development., Alison T. Depew, Timothy J. Mosca
Department of Neuroscience Faculty Papers
As the nervous system develops, connections between neurons must form to enable efficient communication. This complex process of synaptic development requires the coordination of a series of intricate mechanisms between partner neurons to ensure pre- and postsynaptic differentiation. Many of these mechanisms employ transsynaptic signaling via essential secreted factors and cell surface receptors to promote each step of synaptic development. One such cell surface receptor, LRP4, has emerged as a synaptic organizer, playing a critical role in conveying extracellular signals to initiate diverse intracellular events during development. To date, LRP4 is largely known for its role in development of the …
Infection And Risk Of Parkinson's Disease, Richard Jay Smeyne, Alastair J Noyce, Matthew D. Byrne, Rodolfo Savica, Connie Marras
Infection And Risk Of Parkinson's Disease, Richard Jay Smeyne, Alastair J Noyce, Matthew D. Byrne, Rodolfo Savica, Connie Marras
Department of Neuroscience Faculty Papers
Parkinson's disease (PD) is thought to be caused by a combination of genetic and environmental factors. Bacterial or viral infection has been proposed as a potential risk factor, and there is supporting although not entirely consistent epidemiologic and basic science evidence to support its role. Encephalitis caused by influenza has included parkinsonian features. Epidemiological evidence is most compelling for an association between PD and hepatitis C virus. Infection with Helicobacter pylori may be associated not only with PD risk but also response to levodopa. Rapidly evolving knowledge regarding the role of the microbiome also suggests a role of resident bacteria …
A High Affinity, Partial Antagonist Effect Of 3,4-Diaminopyridine Mediates Action Potential Broadening And Enhancement Of Transmitter Release At Nmjs, Kristine S Ojala, Scott P Ginebaugh, Man Wu, Evan W Miller, Gloria Ortiz, Manuel Covarrubias, Stephen D Meriney
A High Affinity, Partial Antagonist Effect Of 3,4-Diaminopyridine Mediates Action Potential Broadening And Enhancement Of Transmitter Release At Nmjs, Kristine S Ojala, Scott P Ginebaugh, Man Wu, Evan W Miller, Gloria Ortiz, Manuel Covarrubias, Stephen D Meriney
Department of Neuroscience Faculty Papers
3,4-Diaminopyridine (3,4-DAP) increases transmitter release from neuromuscular junctions (NMJs), and low doses of 3,4-DAP (estimated to reach ∼1 μM in serum) are the Food and Drug Administration (FDA)-Approved treatment for neuro muscular weakness caused by Lambert-Eaton myasthenic syn drome. Canonically, 3,4-DAP is thought to block voltage-gated potassium (Kv) channels, resulting in prolongation of the pre synaptic action potential (AP). However, recent reports have shown that low millimolar concentrations of 3,4-DAP have an off-Target agonist effect on the Cav1 subtype ("L-Type") of voltage-gated calcium (Cav) channels and have speculated that this agonist effect might contribute to 3,4-DAP effects on transmitter release …